RACK1 deficiency synergizes with all-trans retinoic acid to induce apoptosis in human acute promyelocytic leukemia cells

[1]  Qingyang Wang,et al.  All-trans retinoic acid induces autophagic degradation of ubiquitin-like modifier activating enzyme 3 in acute promyelocytic leukemia cells , 2018, Leukemia & lymphoma.

[2]  K. Takenaka,et al.  The simultaneous inhibition of the mTOR and MAPK pathways with Gnetin-C induces apoptosis in acute myeloid leukemia. , 2017, Cancer letters.

[3]  A. Thorburn,et al.  Targeting autophagy in cancer , 2017, Nature Reviews Cancer.

[4]  Aideen Long,et al.  Roles for RACK1 in cancer cell migration and invasion. , 2017, Cellular signalling.

[5]  L. Jenner,et al.  Structural analysis of ribosomal RACK1 and its role in translational control. , 2017, Cellular signalling.

[6]  Feihu Chen,et al.  Autophagy contributes to 4‐Amino‐2‐Trifluoromethyl‐Phenyl Retinate‐induced differentiation in human acute promyelocytic leukemia NB4 cells , 2017, Toxicology and applied pharmacology.

[7]  Christina Brown,et al.  Retinoic acid and arsenic trioxide in the treatment of acute promyelocytic leukemia: current perspectives , 2017, OncoTargets and therapy.

[8]  E. Estey,et al.  Long-term outcome of acute promyelocytic leukemia treated with all-trans-retinoic acid, arsenic trioxide, and gemtuzumab. , 2017, Blood.

[9]  A. Bagg,et al.  Acute promyelocytic leukemia presenting as a paraspinal mass. , 2016, The Journal of community and supportive oncology.

[10]  G. Bhat,et al.  Acute Coronary Syndrome Manifesting as an Adverse Effect of All-trans-Retinoic Acid in Acute Promyelocytic Leukemia: A Case Report with Review of the Literature and a Spotlight on Management , 2016, Case reports in oncological medicine.

[11]  Qingyang Wang,et al.  RACK1 Promotes Autophagy by Enhancing the Atg14L-Beclin 1-Vps34-Vps15 Complex Formation upon Phosphorylation by AMPK. , 2015, Cell reports.

[12]  Y. Min,et al.  Rosmarinic acid potentiates ATRA-induced macrophage differentiation in acute promyelocytic leukemia NB4 cells. , 2015, European journal of pharmacology.

[13]  Seamus J. Martin,et al.  Inflammatory outcomes of apoptosis, necrosis and necroptosis , 2014, Biological chemistry.

[14]  M. Tschan,et al.  WIPI-dependent autophagy during neutrophil differentiation of NB4 acute promyelocytic leukemia cells , 2014, Cell Death and Disease.

[15]  D. Xie,et al.  RACK1, a versatile hub in cancer , 2014, Oncogene.

[16]  D. Xie,et al.  RACK1 modulates NF-κB activation by interfering with the interaction between TRAF2 and the IKK complex , 2013, Cell Research.

[17]  張依筠.  阿拉伯芥Receptor for Activated C-Kinase 1在乾旱逆境下之功能性研究 , 2014 .

[18]  Qingyang Wang,et al.  RACK1 promotes the proliferation of THP1 acute myeloid leukemia cells , 2013, Molecular and Cellular Biochemistry.

[19]  L. Galluzzi,et al.  EGFR inhibitors exacerbate differentiation and cell cycle arrest induced by retinoic acid and vitamin D3 in acute myeloid leukemia cells , 2013, Cell cycle.

[20]  Hongmei Li,et al.  Oleanolic acid inhibits proliferation and induces apoptosis in NB4 cells by targeting PML/RARα , 2013, Oncology letters.

[21]  Qingyang Wang,et al.  Receptor for activated C kinase 1 promotes hepatocellular carcinoma growth by enhancing mitogen‐activated protein kinase kinase 7 activity , 2013, Hepatology.

[22]  D. Xie,et al.  EphB3 suppresses non-small-cell lung cancer metastasis via a PP2A/RACK1/Akt signalling complex , 2012, Nature Communications.

[23]  Guoqiang Chen,et al.  PML-RARα enhances constitutive autophagic activity through inhibiting the Akt/mTOR pathway , 2011, Autophagy.

[24]  M. Priault,et al.  ATRA-induced upregulation of Beclin 1 prolongs the life span of differentiated acute promyelocytic leukemia cells , 2011, Autophagy.

[25]  D. Tang,et al.  Autophagy regulates myeloid cell differentiation by p62/SQSTM1-mediated degradation of PML-RARα oncoprotein , 2011, Autophagy.

[26]  B. Löwenberg,et al.  Therapeutic advances in acute myeloid leukemia. , 2011, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[27]  M. Bjørås,et al.  Autophagy contributes to therapy-induced degradation of the PML/RARA oncoprotein. , 2010, Blood.

[28]  N. Mizushima,et al.  Autophagy in mammalian development and differentiation , 2010, Nature Cell Biology.

[29]  J. Bertrand,et al.  A New α5β1 Integrin-Dependent Survival Pathway Through GSK3β Activation in Leukemic Cells , 2010, PloS one.

[30]  J. Licht.  Acute promyelocytic leukemia--weapons of mass differentiation. , 2009, The New England journal of medicine.

[31]  H. Saito,et al.  Formation of stress granules inhibits apoptosis by suppressing stress-responsive MAPK pathways , 2008, Nature Cell Biology.

[32]  Guang-Biao Zhou,et al.  Treatment of acute promyelocytic leukaemia with all-trans retinoic acid and arsenic trioxide: a paradigm of synergistic molecular targeting therapy , 2007, Philosophical Transactions of the Royal Society B: Biological Sciences.

[33]  M. Herlyn,et al.  Rewired ERK-JNK signaling pathways in melanoma. , 2007, Cancer Cell.

[34]  Y. Jing.  The PML-RARα Fusion Protein and Targeted Therapy for Acute Promyelocytic Leukemia , 2004 .

[35]  P. Allen,et al.  Modulation of idarubicin-induced apoptosis in human acute myeloid leukemia blasts by all-trans retinoic acid, 1,25(OH)2 vitamin D3, and granulocyte-macrophage colony-stimulating factor. , 1997, Blood.

[36]  E. Ottaviani,et al.  Retinoids increase idarubicin cytotoxicity in human myeloid leukemia cell lines , 1996, Anti-cancer drugs.

[37]  A. Kidman,et al.  Development of drug resistance is reduced with idarubicin relative to other anthracyclines. , 1995, Anti-cancer drugs.

[38]  J. Caldwell,et al.  Cloning of an intracellular receptor for protein kinase C: a homolog of the beta subunit of G proteins. , 1994, Proceedings of the National Academy of Sciences of the United States of America.

[39]  Zhen-yi Wang,et al.  Use of all-trans retinoic acid in the treatment of acute promyelocytic leukemia. , 1988, Haematology and blood transfusion.